ABITREXATE TEVA Israel - englanti - Ministry of Health

abitrexate teva

abic marketing ltd, israel - methotrexate - solution for injection - methotrexate 25 mg/ml - methotrexate - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. palliation of acute lymphocytic leukemia. abitrexate is also indicated in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, abitrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. abitrexate is effective in the treatment of the advanced stages (iii and iv peter's staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. psoriasis: because of the high risk attending its use, abitrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: abitrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.

OXALIPLATIN TEVA Israel - englanti - Ministry of Health

oxaliplatin teva

abic marketing ltd, israel - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5- fluorouracil (5-fu) and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour. - treatment of metastatic colorectal cancer.oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccnguidelines, version 2.2014).

AVCAMOL 500 Israel - englanti - Ministry of Health

avcamol 500

abic marketing ltd, israel - paracetamol - granules - paracetamol 500 mg/stick pack - paracetamol - relief of pain and fever of different etiologies such as headache, toothache, cold, influenza, rheumatic pain and dysmenorrhea

AZITHRO TEVA 200 MG  5 ML Israel - englanti - Ministry of Health

azithro teva 200 mg 5 ml

abic marketing ltd, israel - azithromycin as dihydrate - powder for suspension - azithromycin as dihydrate 200 mg / 5 ml - azithromycin - for the treatment of infections caused by susceptible organisms: in lower respiratory tract including bronchitis and pneumonia, skin and soft tissue infections, otitis media upper respiratory tract infections including sinusitis pharyngitis and tonsillitis. azithro teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

BORTEZ TEVA 3.5 MG Israel - englanti - Ministry of Health

bortez teva 3.5 mg

abic marketing ltd, israel - bortezomib - powder for solution for injection - bortezomib 3.5 mg - bortezomib - bortezo teva is indicated for the treatment of patients with multiple myeloma. bortezo teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezo teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

CEFTAZIDIME TEVA  1 G Israel - englanti - Ministry of Health

ceftazidime teva 1 g

abic marketing ltd, israel - ceftazidime as pentahydrate - powder for solution for injection - ceftazidime as pentahydrate 1 g/vial - ceftazidime - ceftazidime - treatment of single or multiple infections caused by susceptible microorganisms.

ABIPLATIN TEVA Israel - englanti - Ministry of Health

abiplatin teva

abic marketing ltd, israel - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - cisplatin - cisplatin - palliative therapy to be employed either alone, or more commonly in established combination therapy with orher approved chemotherapeutic agents and in patients with metastatic testicular tumor and metastatic ovarian tumor who have alreasy received appropriate surgical and/or radiotherapeutic procedures and in patients with advanced bladder cancer.

OLANZAPINE TEVA  7.5 MG Israel - englanti - Ministry of Health

olanzapine teva 7.5 mg

abic marketing ltd, israel - olanzapine - film coated tablets - olanzapine 7.5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

OLANZAPINE TEVA  10 MG Israel - englanti - Ministry of Health

olanzapine teva 10 mg

abic marketing ltd, israel - olanzapine - film coated tablets - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva is indicated for the management of the manifestations of psychotic disorders. olanzapine teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanzapine teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

OLANZAPINE TEVA  5 MG Israel - englanti - Ministry of Health

olanzapine teva 5 mg

abic marketing ltd, israel - olanzapine - film coated tablets - olanzapine 5 mg - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.